2
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
NIH
1
Study Type
Observational
1
Sponsor
Conditions
Polycystic Ovary Syndrome
10
Insulin Resistance
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Prostatic Neoplasms
4
Diabetes Mellitus, Type 2
4
Pancreatic Neoplasms
3
Diabetes Mellitus
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Metabolic Syndrome
2
Leukoplakia, Oral
2
Leukemia, Myeloid, Chronic-Phase
2
Inflammation
2
Carotid Intimal Medial Thickness 1
2
Breast Neoplasms
2
Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
1
Sleep Apnea, Obstructive
1
Skin Neoplasms
1
Recurrence
1
Prostatic Neoplasms, Castration-Resistant
1
Pharmacokinetics of MDV3100
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Meningioma
1
Memory Disorders
1
Lung Neoplasms
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Leukemia, Myeloid, Acute
1
Interventions
testosterone undecanoate
4
Testosterone
3
Alendronate
2
testosterone 17 beta-cypionate
1
Triptorelin Pamoate
1
Testosterone Propionate
1
Tamoxifen
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Practice Guidelines as Topic
1
Pioglitazone
1
Orchiectomy
1
Observation
1
Methyltestosterone
1
Mental Status and Dementia Tests
1
Gonadotropin-Releasing Hormone
1
Gels
1
Drug Evaluation
1
Clomiphene
1
Castor Oil
1
Blood Specimen Collection
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypogonadism
×
Pioglitazone
×
Clear all
NCT00743327
2012-08-06
ADT
National Institutes of Health Clinical Center (CC)
Terminated
1 enrolled